{"id":25857,"date":"2024-03-25T00:04:00","date_gmt":"2024-03-25T00:04:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4369271_AE69271_0"},"modified":"2024-03-25T00:04:00","modified_gmt":"2024-03-25T00:04:00","slug":"australian-government-grants-tb-alliance-an-award-to-help-bolster-clinical-research-and-improve-access-to-new-treatments-for-drug-resistant-tb","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=25857","title":{"rendered":"Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB"},"content":{"rendered":"\n<p><b><i>AUD 17 Million Grant over 5 Years Will Fund Next-Generation TB Cures <\/i><\/b><\/p>\n<p><span class=\"xn-location\">CANBERRA, Australia<\/span>, <span class=\"xn-chron\">March 25, 2024<\/span> \/PRNewswire\/ &#8212; The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million grant to support work with TB Alliance through its Product Development and Access Partnerships program. The funding will contribute toward the completion of the <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4123242-1&amp;h=2177747288&amp;u=https%3A%2F%2Fwww.tballiance.org%2Fnews%2Ftb-alliance-launches-five-country-phase-2-clinical-trial-evaluating-next-generation-tb-drug-0&amp;a=NC-009\" target=\"_blank\" rel=\"nofollow noopener\">NC-009<\/a> Pan-Phase 2 clinical trial and also help establish and sustain the Peer-to-Peer Learning for Innovative Cures (<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4123242-1&amp;h=3316405413&amp;u=https%3A%2F%2Fwww.peerlinc.org%2F&amp;a=PeerLINC\" target=\"_blank\" rel=\"nofollow noopener\">PeerLINC<\/a>) Knowledge Hub in <span class=\"xn-location\">Manila<\/span>, which will disseminate best practices to help speed the programmatic implementation of innovative, effective tuberculosis treatments, including the World Health Organization (WHO) recommended six-month, all-oral <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4123242-1&amp;h=1709211548&amp;u=https%3A%2F%2Fwww.tballiance.org%2Fpretomanid-who-guidelines&amp;a=BPaL%2FM+regimen\" target=\"_blank\" rel=\"nofollow noopener\">BPaL\/M regimen<\/a>s for drug-resistant tuberculosis (DR-TB).<\/p>\n<p>&quot;Drug-resistant TB is an increasing threat to the health and well-being both in <span class=\"xn-location\">Australia<\/span> and in our neighbouring countries, and in many low- and middle-income countries around the world,&quot; said the Hon. <span class=\"xn-person\">Pat Conroy<\/span>, Minister for International Development and the Pacific. &quot;We are proud of our continued support of the work of TB Alliance, and to help in the rollout of the BPaL\/M regimens and to support the development of the next generation of new TB treatments. These are important steps in the effort to end TB as a major health threat by 2030.&quot;<\/p>\n<p>PeerLINC, which will operate in partnership between TB Alliance and the Tropical Disease Foundation, Inc., will provide practical training, guidance, technical support, field experience, tools, and materials to national TB programs covering a wide range of topics including clinical management, diagnostics, drug safety monitoring, programmatic management, community engagement, and health economics.&nbsp;PeerLINC will continue to guide countries after completion of initial training, as countries work to implement and integrate the BPaL\/M regimens into their national tuberculosis programs.<\/p>\n<p>The <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4123242-1&amp;h=3028704711&amp;u=https%3A%2F%2Fwww.tballiance.org%2Fnews%2Ftb-alliance-launches-five-country-phase-2-clinical-trial-evaluating-next-generation-tb-drug-0&amp;a=NC-009+trial\" target=\"_blank\" rel=\"nofollow noopener\">NC-009 trial<\/a>, which launched in <span class=\"xn-chron\">November 2023<\/span>, will evaluate the safety and efficacy of a combination of a new experimental compound, <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4123242-1&amp;h=3993585901&amp;u=https%3A%2F%2Fwww.tballiance.org%2Fportfolio%2Fcompound%2Ftbaj-876&amp;a=TBAJ-876\" target=\"_blank\" rel=\"nofollow noopener\">TBAJ-876<\/a>, with pretomanid and linezolid, components of the BPaL regimen. This new combination has the potential to shorten and improve treatment for both drug-sensitive and drug-resistant tuberculosis (TB). Results from preclinical and Phase 1 studies presented at the Union Conference showed that TBAJ-876, when compared to bedaquiline (an approved TB medicine in the same drug class), eliminated TB bacteria faster and had a potentially improved safety profile.<\/p>\n<p>&quot;<span class=\"xn-location\">Australia<\/span> has long been a leader in the global health community, and we greatly appreciate their unwavering support in the battle to end TB,&quot; said Dr. <span class=\"xn-person\">Mel Spigelman<\/span>, President and CEO of TB Alliance. &quot;This funding will contribute both to rapidly expanding access to improved treatments, and also to developing the next generation of even more effective TB cures. This award exemplifies the sort of global commitment and political will needed if we hope to, one day, end the TB pandemic.&quot;<\/p>\n<p><b>About TB<\/b><\/p>\n<p>TB is a difficult infection to cure, requiring patients to take a combination of medicines for at least four to six months. Even after symptoms disappear, medicines still need to be taken so that the disease can be fully eradicated. The scope and intensity of TB globally is in large part fueled by antiquated and inadequate TB drugs. Novel drug regimens are urgently needed to bring the TB pandemic under control.<\/p>\n<p><b>About BPaL<\/b><\/p>\n<p>The BPaL regimen\u2014which combines the antibiotics bedaquiline (B), pretomanid (Pa), and linezolid (L)\u2014was first designed and clinically studied by TB Alliance. Pretomanid, as part of the BPaL regimen, received its first regulatory approval in <span class=\"xn-chron\">August 2019<\/span> for use against highly drug-resistant strains of TB. Prior to the initial BPaL clinical trial, less than one -third of drug-resistant TB patients around the world were being successfully treated. Treatment options were limited, expensive, toxic, and lengthy \u2013 requiring patients to take more than 20 pills per day for 9-20 months.<\/p>\n<p><b>About TB Alliance<\/b><\/p>\n<p>TB Alliance is a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight TB. Through innovative science and with partners around the globe, we aim to ensure equitable access to faster, better TB cures that will advance global health and prosperity. TB Alliance operates with support from <span class=\"xn-location\">Australia&#8217;s<\/span> Department of Foreign Affairs and Trade, Bill &amp; Melinda Gates Foundation, Foreign, Commonwealth and Development Office (<span class=\"xn-location\">United Kingdom<\/span>), Cystic Fibrosis Foundation, <span class=\"xn-location\">Germany&#8217;s<\/span> Federal Ministry of Education and Research through KfW, Global Disease Eradication Fund (<span class=\"xn-location\">South Korea<\/span>), Global Health Innovative Technology Fund, <span class=\"xn-person\">Irish Aid<\/span>, Korea International Cooperation Agency, National Institute of Allergy and Infectious Diseases, <span class=\"xn-location\">South Korea&#8217;s<\/span> Ministry of Foreign Affairs, Unitaid, and the United States Agency for International Development. For more information, please visit:&nbsp;<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4123242-1&amp;h=2095956006&amp;u=https%3A%2F%2Fwww.tballiance.org%2F&amp;a=www.tballiance.org\" target=\"_blank\" rel=\"nofollow noopener\">www.tballiance.org<\/a>.&nbsp;<\/p>\n<p>Contact:<br \/><span class=\"xn-person\">Jessica Wiggs<\/span>, +1 (646) 616-8613 \/ <a href=\"mailto:Jessica.Wiggs@tballiance.org\" target=\"_blank\" rel=\"nofollow noopener\">Jessica.Wiggs@tballiance.org<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AUD 17 Million Grant over 5 Years Will Fund Next-Generation TB Cures CANBERRA, Australia, March 25, 2024 \/PRNewswire\/ &#8212; The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million grant to support work with TB Alliance through its Product Development and Access Partnerships program. The funding will [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-25857","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=25857\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB - My Blog\" \/>\n<meta property=\"og:description\" content=\"AUD 17 Million Grant over 5 Years Will Fund Next-Generation TB Cures CANBERRA, Australia, March 25, 2024 \/PRNewswire\/ &#8212; The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million grant to support work with TB Alliance through its Product Development and Access Partnerships program. The funding will [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=25857\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-25T00:04:00+00:00\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=25857#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=25857\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB\",\"datePublished\":\"2024-03-25T00:04:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=25857\"},\"wordCount\":783,\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=25857\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=25857\",\"name\":\"Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"datePublished\":\"2024-03-25T00:04:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=25857#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=25857\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=25857#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=25857","og_locale":"en_US","og_type":"article","og_title":"Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB - My Blog","og_description":"AUD 17 Million Grant over 5 Years Will Fund Next-Generation TB Cures CANBERRA, Australia, March 25, 2024 \/PRNewswire\/ &#8212; The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million grant to support work with TB Alliance through its Product Development and Access Partnerships program. The funding will [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=25857","og_site_name":"My Blog","article_published_time":"2024-03-25T00:04:00+00:00","author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=25857#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=25857"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB","datePublished":"2024-03-25T00:04:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=25857"},"wordCount":783,"articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=25857","url":"https:\/\/transmediavictoria.net.au\/?p=25857","name":"Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"datePublished":"2024-03-25T00:04:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=25857#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=25857"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=25857#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/25857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=25857"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/25857\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=25857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=25857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=25857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}